Written by :
Posted on :

September 3, 2023

Kolosis BIO Recognized as Utah Fast 50 Emerging Company

Kolosis BIO (Kolosis) is proud to announce their recognition as a Utah Fast 50 Emerging Company. Every year, Utah Business awards the fastest growing companies in the state and recognizes emerging companies.

Kolosis, a leading provider of innovative biologics, was among the companies recognized by Utah Business for distinguishing themselves as a strong competitor in the biologics market and making impactful contributions in the industry. This recognition reflects the company’s strategic vision, operational excellence, and the efforts of its dedicated team. Kolosis has shown strong growth throughout 2023 and expects to continue on this trajectory.

As an emerging leader in the biologics industry, Kolosis has demonstrated unwavering resilience and adaptability. This acknowledgement affirms the company’s position as a key player in Utah’s business landscape and sets the stage for continued success in the biotech sector. Kolosis remains committed to bold technologies and relentless execution and is excited to continue innovating through their unmatched access and dedication to real partnerships.

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit